Behrang Kianzad

Behrang Kianzad

Ekstern forsker, Guest Researcher

Member of:

    ORCID: 0000-0002-4508-7467

    Publication year:
    All
    1 - 22 out of 22Page size: 25
    1. 2022
    2. Published

      What Makes A Price (Un)Fair? Excessive Pharmaceutical Pricing in European Competition Law

      Kianzad, Behrang, 26 Jul 2022, København: Det Juridiske Fakultet. 564 p.

      Research output: Book/Report › Ph.D. thesis › Research

    3. Published

      "Compulsory Licensing" in Global Dictionary of Competition Law, Concurrences

      Kianzad, Behrang, 2022, Concurrences. Concurrences, Vol. Art. N° 86433.

      Research output: Chapter in Book/Report/Conference proceeding › Encyclopedia chapter › Research › peer-review

    4. Published

      Temporary Dominance and Excessive Pharmaceutical Pricing – CD Pharma (Denmark)

      Kianzad, Behrang, 2022, EU Competition Law and Pharmaceuticals . Sauter, W., Canoy, M. & Mulder, J. (eds.). Edward Elgar Publishing, p. 124–137 (New Horizons in Competition Law and Economics series).

      Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

    5. Published

      The Giant Awakens: Law and Economics of Excessive Pricing during COVID-19 Crisis

      Kianzad, Behrang, 2022, Law and Economics of the Coronavirus Crisis: New Developments in Competition Law and Economics. Mathis, K. & Tor, A. (eds.). Springer, p. 123–176 (Economic Analysis of Law in European Legal Scholarship; No. 13).

      Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

    6. Published

      The Limits of Control: Competition Law Versus Sector Regulation in the Wake of the European Commission Excessive Pricing Decision in Aspen

      Kianzad, Behrang, 2022, In: European Competition and Regulatory Law Review. 6, 3, p. 207 - 221 14 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    7. Published

      Towards Fair Pricing of Medicines? Lessons from the European Commission's Aspen Decision

      Kianzad, Behrang, 2022, In: European Pharmaceutical Law Review. 6, 1, p. 3 - 23 21 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    8. 2021
    9. Published

      Let´s Dance! Excessive Royalties and the Economic Value of Music (C-372/19 SABAM)

      Kianzad, Behrang, 11 Jun 2021, In: European Competition and Regulatory Law Review. 5, 2, p. 172-176 5 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    10. Published

      Compulsory Licensing

      Kianzad, Behrang, 2021, Encyclopedia of Law and Economics. Marciano, A. & Ramello, G. B. (eds.). New York, NY: Springer New York

      Research output: Chapter in Book/Report/Conference proceeding › Encyclopedia chapter › Research › peer-review

    11. Published

      Excessive Pharmaceutical Pricing as an Abuse of Dominant Position – The Case of CD Pharma (Denmark)

      Kianzad, Behrang, 2021, In: GRUR International. 70, 12, p. 1188-1196 9 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    12. Published

      Excessive Pricing

      Kianzad, Behrang, 2021, Encyclopedia of Law and Economics. Marciano, A. & Ramello, G. B. (eds.). New York, NY: Springer New York

      Research output: Chapter in Book/Report/Conference proceeding › Encyclopedia chapter › Research › peer-review

    13. Published

      Excessive Pricing during COVID-19 crisis in the EU: An Empirical Inquiry

      Kianzad, Behrang, 2021, In: Concurrences. 2021, 1, p. 250-259 10 p., 98670.

      Research output: Contribution to journal › Journal article › Research › peer-review

    14. Published

      The Giant Awakens - Law and Economics of Excessive Pricing & COVID-19 Crisis

      Kianzad, Behrang, 2021.

      Research output: Contribution to conference › Paper › Research

    15. Published

      ‘No-one is Safe Until Everyone is Safe’ – Patent Waiver, Compulsory Licensing and COVID-19

      Kianzad, Behrang & Wested, Jakob, 2021, In: European Pharmaceutical Law Review. 5, 2, p. 71-91 21 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    16. 2020
    17. Published

      No Copyright Protection for a Footwear Design

      Kianzad, Behrang (Translator), 22 Dec 2020, In: GRUR International. 70, 2, p. 200-204 5 p.

      Research output: Contribution to journal › Journal article › Commissioned › peer-review

    18. Published

      Did the Danish Supreme Court Give the Fashion Industry the Kantian Boot?

      Kianzad, Behrang, 9 Dec 2020, In: GRUR International. 70, 2, p. 159-163 5 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    19. Published

      Legal Remedies In Times of Global Pandemic Crisis-Price Gouging, Compulsory Licensing and the role of Antitrust

      Kianzad, Behrang & Minssen, Timo, 23 Oct 2020.

      Research output: Contribution to conference › Paper › Research

    20. Published

      SWEDEN’s Response to COVID-19: A tale of trust, recommendations, and odorous nudges: Available at: https://blog.petrieflom.law.harvard.edu/2020/05/12/sweden-global-responses-covid19/

      Kianzad, Behrang & Minssen, Timo, May 2020, Harvard Law School's Bill of Health blog.

      Research output: Other contribution › Net publication - Internet publication › Research › peer-review

    21. Published

      De minimis exception when using applied art in marketing materials

      Kianzad, Behrang, 1 Jan 2020, In: GRUR International. 69, 1, p. 91-105 15 p.

      Research output: Contribution to journal › Journal article › Commissioned › peer-review

    22. Published

      Konkurrensrättsliga aspekter av Corona-krisen

      Kianzad, Behrang, 2020, Dagens Juridik.

      Research output: Other contribution › Research

    23. 2019
    24. Published

      Würtz v. Coop - Decision of the Danish Supreme Court 18 December 2018 – Case No. 171/2017

      Kianzad, Behrang (Translator), 25 Nov 2019, In: I I C - International Review of Intellectual Property and Competition Law. p. 109-112 4 p.

      Research output: Contribution to journal › Journal article › Commissioned › peer-review

    25. Published

      Excessive Pharmaceutical Prices as an Anticompetitive Practice in TRIPS and European Competition Law

      Kianzad, Behrang, 15 Mar 2019, New Developments in Competition Law and Economics. Mathis, K. & Tor, A. (eds.). Springer, p. 197-220 24 p.

      Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

    26. 2018
    27. Published

      How much is too much?- Defining the Metes and Bounds of Excessive Pricing in the Pharmaceutical Sector

      Kianzad, Behrang & Minssen, Timo, 2018, In: European Pharmaceutical Law Review. 2, 3, p. 133-148 16 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 182567918